Judge Denies Mylan And Aurobindo's Bid To Escape Trial

By Jonathan Capriel · February 19, 2026, 11:03 PM EST

A Connecticut federal judge has once again rejected generic-drug makers' bid to escape a multistate lawsuit accusing them of engaging in an overarching antitrust conspiracy, saying the evidence supports the need...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Connecticut et al v. Sandoz, Inc. et al

Case Number

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

June 10, 2020

Recent Articles By Jonathan

February 18, 2026
Blue Shield Of Calif. Says 'Ghost Network' Action Falls Flat
February 13, 2026
FDA Removes Boxed Warnings From HRT Products
February 11, 2026
Zipper Malfunction In Hyperbaric Chamber Leads to Lawsuit
February 10, 2026
US Says Abbott Lied, Must Repay Funds Spent On Formula
December 03, 2025
FDA Seizes $1M In Illegal 7-OH Opioid Products
November 14, 2025
Texas Judge Rejects Bid To Block Kenvue's $398M Dividend
November 13, 2025
CVS Reaches Deal In 'Non-Drowsy' Labeling Class Action
November 12, 2025
Valsartan Cancer Expert Blocked, Ending First Injury Trial
November 04, 2025
Dad Expands Wrongful Death Claims In Ketamine Overdose Suit
October 23, 2025
SEC Being Misled In CBD Fraud Fight, CEO Claims